INKON Life Technology Co Ltd
SZSE:300143
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
6.75
10.99
|
| Price Target |
|
We'll email you a reminder when the closing price reaches CNY.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
INKON Life Technology Co Ltd
Gross Margin
INKON Life Technology Co Ltd
Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.
Gross Margin Across Competitors
| Country | CN |
| Market Cap | 5.1B CNY |
| Gross Margin |
26%
|
| Country | US |
| Market Cap | 83.9B USD |
| Gross Margin |
85%
|
| Country | SA |
| Market Cap | 98B SAR |
| Gross Margin |
35%
|
| Country | ZA |
| Market Cap | 24.9B Zac |
| Gross Margin |
21%
|
| Country | ZA |
| Market Cap | 20.7B Zac |
| Gross Margin |
49%
|
| Country | CN |
| Market Cap | 133.2B CNY |
| Gross Margin |
50%
|
| Country | MY |
| Market Cap | 63.3B MYR |
| Gross Margin |
71%
|
| Country | US |
| Market Cap | 13.7B USD |
| Gross Margin |
83%
|
| Country | US |
| Market Cap | 13.1B USD |
| Gross Margin |
0%
|
| Country | TH |
| Market Cap | 421.1B THB |
| Gross Margin |
37%
|
| Country | IN |
| Market Cap | 997.2B INR |
| Gross Margin |
49%
|
INKON Life Technology Co Ltd
Glance View
INKON Life Technology Co., Ltd. engages in the research, development, production and sale of edible fungus. The company is headquartered in Qingdao, Shandong and currently employs 1,791 full-time employees. The company went IPO on 2011-04-22. Its medical services focus on cancer prevention, diagnosis, treatment and rehabilitation. The firm is also engaged in the research and development, manufacture and sales of medical equipment, as well as medical software development. Its medical equipment mainly include MASEP digital radiotherapy equipment, MASEP Gamma Knife and other large medical equipment. The firm distributes its products within domestic market and to overseas markets.
See Also
Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.
Based on INKON Life Technology Co Ltd's most recent financial statements, the company has Gross Margin of 25.6%.
You don't have any saved screeners yet
